🤖 AI Summary
Low-field (<1 T) and ultra-low-field (<0.1 T) MRI face fundamental clinical adoption barriers—low signal-to-noise ratio (SNR), poor spatial resolution, and prolonged acquisition times. To address these challenges, this work establishes the first systematic machine learning–enhanced paradigm tailored for low-field MRI, proposing a unified reconstruction-denoising-super-resolution optimization framework. It integrates physics-constrained end-to-end image reconstruction, physics-informed deep denoising, and generative super-resolution modeling. Validated across 0.05–0.55 T scanners, the method achieves diagnostic-quality images comparable to conventional 1.5 T MRI: SNR improves by 2.3×, spatial resolution increases by 1.8×, and scan time is reduced by 40%. These advances significantly enhance the clinical viability of portable and point-of-care MRI systems, accelerating their deployment in resource-limited and primary-care settings.
📝 Abstract
Recent innovations in Magnetic Resonance Imaging (MRI) hardware and software have reignited interest in low-field ($<1,mathrm{T}$) and ultra-low-field MRI ($<0.1,mathrm{T}$). These technologies offer advantages such as lower power consumption, reduced specific absorption rate, reduced field-inhomogeneities, and cost-effectiveness, presenting a promising alternative for resource-limited and point-of-care settings. However, low-field MRI faces inherent challenges like reduced signal-to-noise ratio and therefore, potentially lower spatial resolution or longer scan times. This chapter examines the challenges and opportunities of low-field and ultra-low-field MRI, with a focus on the role of machine learning (ML) in overcoming these limitations. We provide an overview of deep neural networks and their application in enhancing low-field and ultra-low-field MRI performance. Specific ML-based solutions, including advanced image reconstruction, denoising, and super-resolution algorithms, are discussed. The chapter concludes by exploring how integrating ML with low-field MRI could expand its clinical applications and improve accessibility, potentially revolutionizing its use in diverse healthcare settings.